300347 泰格醫藥
按盤價 
59.880 +0.790 (+1.337%)
59.880 +0.790 (+1.337%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 5,025,868 | -0.82% | 6,603,120 | 7,384,039 | 7,085,471 | 5,213,538 | |
| 減：營業總成本 | 4,559,527 | 13.24% | 5,610,048 | 5,554,125 | 5,156,544 | 3,637,765 | |
| 其中:營業成本 | 3,560,252 | 14.95% | 4,361,107 | 4,535,511 | 4,277,008 | 2,942,883 | |
| 財務費用 | 76,160 | 142.77% | 38,067 | (108,324) | (158,124) | (216,363) | |
| 資產減值損失 | (5,402) | -49.31% | 1,255 | (29,725) | (2,416) | (12,915) | |
| 公允價值變動收益 | 323,191 | -1,039.18% | (501,688) | 352,771 | 535,857 | 1,815,390 | |
| 投資收益 | 440,221 | 303.29% | 166,642 | 338,175 | 102,751 | 312,283 | |
| 其中：對聯營企業和合營企業的投資收益 | -- | -- | 31,271 | 105,183 | 39,763 | 14,348 | |
| 營業利潤 | 1,229,009 | 13.27% | 664,419 | 2,486,941 | 2,582,399 | 3,696,967 | |
| 利潤總額 | 1,222,781 | 12.48% | 664,462 | 2,488,533 | 2,585,377 | 3,684,566 | |
| 減：所得稅費用 | 131,100 | -28.72% | 216,630 | 338,606 | 313,652 | 292,864 | |
| 淨利潤 | 1,091,681 | 20.88% | 447,831 | 2,149,927 | 2,271,725 | 3,391,702 | |
| 減：非控股權益 | 71,247 | -20.58% | 42,688 | 125,077 | 265,173 | 517,539 | |
| 股東淨利潤 | 1,020,434 | 25.45% | 405,143 | 2,024,850 | 2,006,552 | 2,874,163 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.190 | 26.60% | 0.470 | 2.340 | 2.320 | 3.310 | |
| 每股派息 (元) * | -- | -- | 0.300 | 0.568 | 0.550 | 0.500 | |
| 每股淨資產 (元) * | 24.594 | 0.99% | 23.898 | 24.102 | 22.447 | 20.774 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 31/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
